Market Crash Alert: How the Cannabis Bubble Affects All Stocks

Learn how the cannabis bubble tells us what is to come, using Canopy Growth Corp (TSX:WEED)(NYSE:CGC) as an example.

Photo of a floating bubble

Image source: Getty Images.

You’re reading a free article with opinions that may differ from The Motley Fool’s premium investing services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn moresdf

Investors that have lost their shirts with various Canadian cannabis stocks over the past year can attest the pain of a bubble and stock prices. Valuations are now at levels that, by some metrics, are at all-time highs. Therefore, investors ought to be more cautious with making large investments in any company right now. In this article, I’m going to discuss some of the lessons learned from the cannabis bubble, which we saw pop recently.

Earnings matter

The “growth-at-any-price” investment mandate of so many momentum investors in 2018 and 2019 led to valuation increases. In hindsight, these increases were absurd for cannabis stocks. Expectations of revenue growth and eventual profitability in a year or two (this year or next) determined stock prices rather than fundamentals.

Cannabis producers were scrambling to acquire production capacity at any cost. They had no regard for profitability at the time. There was a marked shift in investor sentiment related to the weaker-than-expected revenue growth. This was ultimately tied to demand that did not materialize. Subsequently, stock prices plummeted. As many investors have seen, some cannabis producers have seen stock price declines north of 90% from their peaks.

The overall stock market today is by no means as irresponsibly priced as the cannabis sector was 18 months ago. That said, some of the same concerns of growth expectations being way too bullish and demand failing to materialize are real.

The rebound in demand for almost any good right now that is being priced into the stock market is, in my opinion, unrealistic. Investors should pay attention to the structural economic issues that are likely to influence earnings when making assessments of the value of any company.

Cost cutting is not bullish

As we have seen with one of Canada’s largest cannabis producers, Canopy Growth, cost cutting has become the name of the game in the cannabis sector. Instead of adding production capacity, companies like Canopy have been shuttering plants and laying off workers. Their goal is to widen margins and produce cash flow and profitability sooner.

The sharp fall out of expected demand has created an environment in which survival has become the primary goal of management teams across the sector. Even these management teams have seen significant turnover of late.

I expect we’ll see similar measures take hold in a swath of sectors in the coming quarters. Consumer and corporate demand for goods and services will flatline or decline. This potential spiral, similar to the one experienced in the cannabis sector, would be structural.

This means monetary and fiscal stimulus measures would likely not have the desired impact investors today are banking on. A reduction in the efficacy of government intervention in the economy is not in any way priced into the stock market right now. Lowering interest rates to below zero, for example, is unlikely to persuade a company to hire back thousands of laid-off employees. However, you couldn’t tell that by watching how stocks react to stimulus news.

Stay Foolish, my friends.

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium service or advisor. We’re Motley! Questioning an investing thesis — even one of our own — helps us all think critically about investing and make decisions that help us become smarter, happier, and richer, so we sometimes publish articles that may not be in line with recommendations, rankings or other content.

Fool contributor Chris MacDonald has no position in any of the stocks mentioned.

More on Cannabis Stocks

Cannabis smoke
Cannabis Stocks

Canopy Growth Stock: Is Now a Good Time to Invest?

The road ahead is highly uncertain for Canopy Growth, as the stock is plagued with losses and seemingly unsurmountable industry…

Read more »

Cannabis grows at a commercial farm.
Cannabis Stocks

TLRY Stock: Should You Invest Now?

TLRY is a Canadian cannabis stock which is trading 91% below record highs. Let's see if you should own TLRY…

Read more »

Cannabis grows at a commercial farm.
Cannabis Stocks

Is Tilray Stock a Buy in February 2023?

Despite the volatile cannabis sector, Tilray could be a superb buy for long-term investors.

Read more »

Young woman sat at laptop by a window
Cannabis Stocks

Is SNDL Stock a Buy in February 2023?

SNDL is a beaten-down cannabis stock. While its revenue growth is exceptional, a weak balance sheet has driven stock prices…

Read more »

A cannabis plant grows.
Cannabis Stocks

TLRY Stock: Here’s What’s Coming in 2023

Tilray Inc. (TSX:TLRY) is geared up for big growth this decade and looks like one of the top cannabis stocks…

Read more »

A person holds a small glass jar of marijuana.
Cannabis Stocks

Canopy Growth Stock: Here’s What’s Coming in 2023

Canopy Growth stock has made a lot of new moves in the last few months, but where is the company…

Read more »

A cannabis plant grows.
Cannabis Stocks

Better Cannabis Buy: Canopy Growth Stock or Tilray?

Only two TSX weed stocks can deliver substantial returns in the highly anticipated growth of the global cannabis market.

Read more »

Medicinal research is conducted on cannabis.
Cannabis Stocks

Is Tilray Stock a Buy in January 2023?

Tilray stock has lost 50% of its value in the last 12 months, in line with its peers.

Read more »